GLP-1 injections mimic a natural hormone that regulates appetite, slows digestion, and helps control blood sugar levels
The relationship between dysregulated insulin metabolism and migraine involves several interconnected pathways: TRPV1 sensitization and CGRP release, mitochondrial dysfunction with oxidative stress, and systemic and neurogenic inflammation
Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Erondu N, Shaw W, et al
So, for these patients, if there are indications for a diabetes or weight loss medication, it may make sense to prescribe a GLP-1 receptor agonist. Advertisement Advertisement The drug does not provide lasting disease control for most patients A review of pathophysiology, risk factors, clinical presentation and treatment options Registry data highlight visual gains in patients with legal blindness Its the first step toward reliable screening with your smartphone Fixational eye movement is similar in left and right eyes of people with normal vision Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation A new online calculator can determine probability of melanoma Only 33% of patients have long-term improvement after treatment
Approval for Cardiovascular Risk Reduction Ongoing cardiovascular outcomes trials (CVOT) studies clearly demonstrated that three of the diabetes incretin medications (liraglutide, dulaglutide and semaglutide) and one of the weight loss versions of this class (Wegovy) also reduce cardiovascular disease risk
This article will explore how GLP-1 medications work, what the latest research shows, and how these treatments might help you get better sleep
)
